摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-methoxy-1,2,3,4,5,6-hexahydro-azepino[4,5-b]indole | 15918-90-8

中文名称
——
中文别名
——
英文名称
9-methoxy-1,2,3,4,5,6-hexahydro-azepino[4,5-b]indole
英文别名
9-Methoxy-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole
9-methoxy-1,2,3,4,5,6-hexahydro-azepino[4,5-<i>b</i>]indole化学式
CAS
15918-90-8
化学式
C13H16N2O
mdl
——
分子量
216.283
InChiKey
JPOYXJNQVUWKEI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    37
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    9-methoxy-1,2,3,4,5,6-hexahydro-azepino[4,5-b]indole2-(甲基磺酰基)-5-嘧啶羧酸甲酯potassium carbonate 作用下, 以 乙腈 为溶剂, 反应 4.0h, 以13.3%的产率得到methyl 2-(9-methoxy-1,4,5,6-tetrahydroazepino[4,5-b]indol-3(2H)-yl)pyrimidine-5-carboxylate
    参考文献:
    名称:
    WO2006/88949
    摘要:
    公开号:
  • 作为产物:
    描述:
    [2-(2-Dibenzylamino-ethyl)-5-methoxy-1H-indol-3-yl]-acetonitrile 在 palladium on activated charcoal 氢气 作用下, 以 溶剂黄146 为溶剂, 反应 48.0h, 以80%的产率得到9-methoxy-1,2,3,4,5,6-hexahydro-azepino[4,5-b]indole
    参考文献:
    名称:
    六氢氮杂环庚烷[4,5- b ]-和六氢偶氮芥子[4,5- b ]吲哚的实用合成
    摘要:
    2-(2-苄基氨基乙基)-3-氰基甲基吲哚的催化加氢(Pd·C)以良好的收率得到了六氢氮杂环庚烷[4,5-b]吲哚。在相同条件下,将2-(2-苄基氨基乙基)-3氰基乙基吲哚环化为六氢偶氮并[4,5-b]吲哚。
    DOI:
    10.1016/0040-4039(95)00530-p
点击查看最新优质反应信息

文献信息

  • Inhibitors of histone deacetylase
    申请人:Anandan K. Sampath
    公开号:US20060199829A1
    公开(公告)日:2006-09-07
    Disclosed are compounds of formula I that inhibit histone deacetylase (HDAC) enzymatic activity, pharmaceutical compositions comprising such compounds, as well as methods to treat conditions, particularly proliferative conditions, mediated at least in part by HDAC, wherein A, W, W 1 , W 2 , Ar 2 , and G are described herein.
    本发明涉及公式I的化合物,其抑制组蛋白去乙酰化酶(HDAC)酶活性,包括这样的化合物的制药组合物,以及用于治疗至少部分由HDAC介导的疾病,特别是增殖性疾病的方法,其中A,W,W1,W2,Ar2和G如本文所述。
  • US7772245B2
    申请人:——
    公开号:US7772245B2
    公开(公告)日:2010-08-10
  • WO2006/88949
    申请人:——
    公开号:——
    公开(公告)日:——
  • Practical syntheses of hexahydroazepino[4,5-b]- and hexahydroazocino[4,5-b]indoles
    作者:Khalid Diker、Michèle Döé de Maindreville、Jean Lévy
    DOI:10.1016/0040-4039(95)00530-p
    日期:1995.5
    Catalytic hydrogenation (Pd·C) of 2-(2-benzylaminoethyl)-3-cyanomethyl indoles gave hexahydroazepino[4,5-b]indoles in good yields. 2-(2-Benzylaminoethyl)-3 cyanoethyl indoles were cyclized to hexahydroazocino[4,5-b]indoles under identical conditions.
    2-(2-苄基氨基乙基)-3-氰基甲基吲哚的催化加氢(Pd·C)以良好的收率得到了六氢氮杂环庚烷[4,5-b]吲哚。在相同条件下,将2-(2-苄基氨基乙基)-3氰基乙基吲哚环化为六氢偶氮并[4,5-b]吲哚。
查看更多

同类化合物

环戊二烯并[4,5]氮杂卓并[2,1,7-cd]吡咯里嗪 吡咯并[1,2-a]氮杂-5-酮 六氢-1H-吡咯并[1,2-A]氮杂卓-5(6H)-酮 N,N-二甲基-3-(3-甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)丙-1-胺 9-氟-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 7,8-二氢-5H-吡咯并[1,2-A]氮杂环庚烷-9(6H)-酮 6-叔-丁基3A-乙基八氢吡咯并[2,3-D]氮杂卓-3A,6(2H)-二甲酸基酯 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 5H-吡咯并[1,2-a]氮杂卓-7-醇 5,9:7,11-二亚甲基-5H-吡咯并[1,2-a]吖壬英-3-羧酸,6,7,8,9,10,11-六氢-,甲基酯 4-(2-氨基-1H-咪唑-5-基)-2,3-二溴-6,7-二氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1H-咪唑-4-基)-2,3-二溴-4,5,6,7-四氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1,5-二氢-5-氧代-4H-咪唑-4-亚基)-4,5,6,7-四氢-吡咯并[2,3-c]氮杂卓-8(1H)-酮 3-苄基-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 3-(3,9-二甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)-N,N-二甲基丙烷-1-胺 2H,3H-氧杂环丁烷并[3,2-d]吡咯并[1,2-a]氮杂卓 2-溴-6,7-二氢-1h,5h-吡咯并[2,3-c]氮杂烷-4,8-二酮 2,5-已炔二醇 2,3,4,5-四氢-N,N-二甲基-2-(3,4,5-三甲氧基苯甲酰基)-氮杂卓并(3,4-b)吲哚-10(1H)-丙胺 11-氧杂-3,10-二氮杂三环[7.2.1.03,7]十二碳-1,4,6,9-四烯 1,4,5,6,7,8-六氢吡咯并[3,2-b]氮杂卓 1,2,3,4,5,6-六氢氮杂环庚烷[4,3-B]吲哚盐酸盐 1,2,3,4,5,6-六氢-9-甲基氮杂卓并[4,5-b]吲哚 1,2,3,4,5,6-六氢-6-甲基氮杂革[4,5-b]吲哚盐酸盐 1,2,3,4,5,6-六氢-3-甲基氮杂卓并[4,5-b]吲哚 (1R*,2E,11S*)-2-(cyclohexylmethylene)-1-(phenylsilyl)methyloctahydropyrrolo[1,2-a]azepine (R)-2-(6,7,8,9-tetrahydro-5H-pyrrolo[1,2-a]azepin-9-yl)-acetaldehyde curvulamine (3aR,8aS)-tert-butyl octahydropyrrolo[3,4-d]azepine-2(1H)-carboxylate hydrochloride tert-butyl 6-(2-amino-2-oxoethyl)-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate 3-benzoyl-10-bromo-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-(tert-butyloxycarbonyl)-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethylazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethyl-6-methylazepino[4,5-b]indole (Z)-2,3,9,9a-tetrahydro-6,6-dimethyl-9-methylene-8-vinyl-1H-pyrrolo[1,2-a]azepin-5(6H)-one 2,3,4,5,6,7-hexahydro-1H-3a,8,13,13b-tetraazabenzo[b]cyclopenta[1,2,3-jk]fluorene 2,3,4,5,6,7-hexahydro-1H-3a,8,11,11b-tetraazacyclohepta[1,2,3-jk]fluorene 1-Benzyloxy-2-methoxy-7,8,9,10-tetrahydro-6H-azepino<1,2-a>indole-11-carbaldehyde 3-benzoyl-10-(2-propoxyphenyl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 2-phenyl-2,4,5,6-tetrahydro-1H-6-azabenzo[a]cyclohepta[cd]azulen-1-one 2-carbetoxy-3-(N,N-dimethyl)aminomethyleneamino-8-oxo-8H-4,5,6,7-tetrahydropyrrolo<2,3-c>azepine 3-benzoyl-10-[2-(trifluoromethyl)phenyl]-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-benzoyl-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 6-[2-(4-fluorophenyl)ethyl]-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 5-(2-hydroxy-3-morpholin-4-yl-propyl)-3-methyl-4-oxo-1,4,5,6,7,8-hexahydro-pyrrolo[3,2-c]azepine-2-carbaldehyde 6-(2-phenylethyl)-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 11-(tert-butyldimethylsilyloxy)-1-trimethylsilyl-3a,4,11,12-tetrahydro-3H-cyclopenta[5,6]azepine[1,2-a]indole-2-one tert-butyl 8,9-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl 9,10-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl (1R,4S)-1-(benzylcarbamoyl)-3-oxo-2-((S)-1-phenylethyl)-1,2,3,4,5,10-hexahydroazepino[3,4-b]indol-4-ylcarbamate